• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • EVOQ Announces License, Collaboration Agreement with Amgen americanpharmaceuticalreview
    January 21, 2021
    ​EVOQ Therapeutics announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders.
  • EVOQ Therapeutics and Amgen Partner contractpharma
    January 14, 2021
    ​EVOQ Therapeutics has signed a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders.
  • Sanofi to acquire Synthorx for $2.5 B biospectrumasia
    December 12, 2019
    Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service